Related Experiment Videos
Prevalence of and recent developments in female sexual dysfunction
1Department of Urology, Columbia-Presbyterian Medical Center, 161 Fort Washington Avenue, New York, NY 10032, USA. rs 66@columbia.edu
Current Psychiatry Reports
|May 17, 2001
Summary
Female sexual dysfunction (FSD) research is rapidly advancing, spurred by male erectile dysfunction treatments. This article explores FSD prevalence and recent scientific developments in understanding and treating this condition.
Area of Science:
- Reproductive Medicine
- Pharmacology
- Women's Health
Background:
- Female sexual dysfunction (FSD) has gained prominence, partly due to the success of oral pharmacotherapy for male erectile dysfunction.
- This success prompted investigations into the efficacy of similar vascular medications for FSD.
- The field has expanded, generating further research questions regarding female sexual health.
Purpose of the Study:
- To review the current prevalence of female sexual dysfunction.
- To discuss the latest advancements and research directions in the field of FSD.
- To provide an overview of the evolving understanding of FSD.
Main Methods:
- Literature review of recent studies on female sexual dysfunction.
- Analysis of pharmacological developments related to FSD treatment.
- Synthesis of data on FSD prevalence and emerging research trends.
Main Results:
- Significant research interest in FSD has emerged.
- The success of male erectile dysfunction drugs has influenced FSD research.
- The field is characterized by ongoing inquiry and evolving understanding.
Conclusions:
- Female sexual dysfunction is a complex area with growing research focus.
- Pharmacological and vascular mechanisms are key areas of investigation.
- Continued research is essential to address the prevalence and complexities of FSD.